89bio, Inc. (ETNB) Misses Q2 EPS by 6c

89bio, Inc. (NASDAQ: ETNB) reported Q2 EPS of ($0.52), $0.06 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
• MotorK names Roy Toren to board as Helen Protopapas resigns